2018 Vol.36, N°3 - Suppl.112 - Table of contents

Sjögren’s syndrome 2018

First Annual Supplement on Sjögren’s syndrome

Guest Editors: M. Bombardieri, S. De Vita, T. Dörner, M. Ramos-Casals, A.G. Tzioufas

Meeting Report

CER11474
2018,36,3,Suppl.112
Pg. 0003-0013

Free to view

Highlights of the 14th International Symposium in Sjögren’s Syndrome
M. Bombardieri, C. Baldini, I. Alevizos, E. Akpek, A.N. Baer

One year in review

CER11493
2018,36,3,Suppl.112
Pg. 0014-0026

Free to view

One year in review 2018: Sjögren’s syndrome
O.D. Argyropoulou, E. Valentini, F. Ferro, M.C. Leone, G. Cafaro, E. Bartoloni, C. Baldini

Editorials

CER11304
2018,36,3,Suppl.112
Pg. 0027-0028

Free to view

Limited efficacy of targeted treatments in Sjögren’s syndrome: why?
A.G. Tzioufas, A.V. Goules

CER11303
2018,36,3,Suppl.112
Pg. 0029-0030

Free to view

Sjögren's syndrome: disease activity indexes! Do they make us better clinicians or technicians?
H.M. Moutsopoulos, F.N. Skopouli

Aetiopathogenesis

CER10168
2018,36,3,Suppl.112
Pg. 0031-0040

Free to view

Increased expression of interferon-λ in minor salivary glands of patients with primary Sjögren's syndrome and its synergic effect with interferon-α on salivary gland epithelial cells
Y.-J. Ha, Y.S. Choi, E.H. Kang, J.-H. Chung, S. Cha, Y.W. Song, Y.J. Lee

CER10728
2018,36,3,Suppl.112
Pg. 0041-0046

Free to view

Immune response against the coiled coil domain of Sjögren’s syndrome associated autoantigen Ro52 induces salivary gland dysfunction
M. Sroka, H. Bagavant, I. Biswas, A. Ballard, U.S. Deshmukh

CER10974
2018,36,3,Suppl.112
Pg. 0047-0050

Free to view

Proprotein convertase enzyme FURIN is upregulated in primary Sjögren's syndrome
N. Ranta, A. Valli, A. Grönholm, O. Silvennoinen, P. Isomäki, M. Pesu, M. Pertovaara

CER11027
2018,36,3,Suppl.112
Pg. 0051-0060

Free to view

Detection of human T lymphotropic virus type-I bZIP factor and tax in the salivary glands of Sjögren’s syndrome patients
H. Nakamura, H. Hasegawa, D. Sasaki, A. Takatani, T. Shimizu, S. Kurushima, Y. Horai, Y. Nakashima, T. Nakamura, J. Fukuoka, A. Kawakami

CER11480
2018,36,3,Suppl.112
Pg. 0061-0067

Free to view

Autoantibodies to ox-LDL in Sjögren’s syndrome: are they atheroprotective?
I. Cinoku, C.P. Mavragani, C.C. Tellis, A. Nezos, A.D. Tselepis, H.M. Moutsopoulos

Clinical aspects

CER10163
2018,36,3,Suppl.112
Pg. 0068-0072

Free to view

Psychological comorbidities associated with subclinical atherosclerosis in Greek patients with primary Sjögren’s syndrome: a potential contribution of sleep impairment
T. Karageorgas, D. Ioakeimidis, C.P. Mavragani

CER10350
2018,36,3,Suppl.112
Pg. 0073-0079

Free to view

Prevalence and significance of anti-saccharomyces cerevisiae antibodies in primary Sjögren’s syndrome
A. Alunno, O. Bistoni, F. Carubbi, V. Valentini, G. Cafaro, E. Bartoloni, R. Giacomelli, R. Gerli

CER10325
2018,36,3,Suppl.112
Pg. 0080-0088

Free to view

Minor salivary gland fibrosis in Sjögren’s syndrome is elevated, associated with focus score and not solely a consequence of aging
K.M. Leehan, N.P. Pezant, A. Rasmussen, K. Grundahl, J.S. Moore, L. Radfar, D.M. Lewis, D.U. Stone, C.J. Lessard, N.L. Rhodus, B.M. Segal, R.H. Scofield, K.L. Sivils, C. Montgomery, A.D. Farris

CER10453
2018,36,3,Suppl.112
Pg. 0089-0093

Free to view

IgG4-related disease: features and treatment response in a multi-ethnic cohort in Singapore
W. Fong, I. Liew, D. Tan, K.H. Lim, A. Low, Y.Y. Leung

CER11077
2018,36,3,Suppl.112
Pg. 0094-0101

Free to view

Prevalence and spectrum of symptomatic pulmonary involvement in primary Sjögren’s syndrome
C.F. Kampolis, S. Fragkioudaki, C.P. Mavragani, A. Zormpala, A. Samakovli, H.M. Moutsopoulos

CER11329
2018,36,3,Suppl.112
Pg. 0102-0112

Free to view

How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project)
P. Brito-Zerón, N. Acar-Denizli, W.-F. Ng, M. Zeher, A. Rasmussen, T. Mandl, R. Seror, X. Li, C. Baldini, J.-E. Gottenberg, D. Danda, L. Quartuccio, R. Priori, G. Hernandez-Molina, B. Armagan, A.A. Kruize, S.-K. Kwok, M. Kvarnström, S. Praprotnik, D. Sène, E. Bartoloni, R. Solans, M. Rischmueller, Y. Suzuki, D.A. Isenberg, V. Valim, P. Wiland, G. Nordmark, G. Fraile, H. Bootsma, T. Nakamura, R. Giacomelli, V. Devauchelle-Pensec, A. Knopf, M. Bombardieri, V.-F. Trevisani, D. Hammenfors, S.G. Pasoto, S. Retamozo, T.A. Gheita, F. Atzeni, J. Morel, C. Vollenveider, I.-F. Horvath, K.L. Sivils, P. Olsson, S. De Vita, J. Sánchez-Guerrero, L. Kilic, M. Wahren-Herlenius, X. Mariette, M. Ramos-Casals
on behalf of the Sjögren Big Data Consortium

CER11370
2018,36,3,Suppl.112
Pg. 0113-0120

Free to view

The prevalence and relevance of traditional cardiovascular risk factors in primary Sjögren’s syndrome
E. Bartoloni, A. Alunno, V. Valentini, E. Valentini, G.M.C. La Paglia, M.C. Leone, G. Cafaro, E. Marcucci, A.F. Bonifacio, F. Luccioli, R. Gerli

CER11326
2018,36,3,Suppl.112
Pg. 0121-0129

Free to view

Severe, life-threatening phenotype of primary Sjögren's syndrome: clinical characterisation and outcomes in 1580 patients (GEAS-SS Registry)
A. Flores-Chávez, B. Kostov, R. Solans, G. Fraile, B. Maure, C. Feijoo-Massó, F.-J. Rascón, R. Pérez-Alvarez, M. Zamora-Pasadas, A. García-Pérez, M. Lopez-Dupla, M.-Á. Duarte-Millán, M. Ripoll, E. Fonseca-Aizpuru, P. Guisado-Vasco, B. Pinilla, G. De-La-Red, A.-J. Chamorro, C. Morcillo, P. Fanlo, M.J. Soto-Cárdenas, S. Retamozo, M. Ramos-Casals, P. Brito-Zerón
on behalf of the GEAS-SS SEMI Registry

CER11364
2018,36,3,Suppl.112
Pg. 0130-0136

Free to view

Do I sound dry? Comparative voice analysis of primary Sjögren’s syndrome
S.-Y. Kim, J. Lee, Y.-S. Choi, J.-W. Kim, S.-K. Kwok, Y.-H. Park, D.-I. Sun, S.-H. Park

CER11471
2018,36,3,Suppl.112
Pg. 0137-0144

Free to view

Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren’s syndrome
C. Baldini, F. Ferro, N. Luciano, S. Bombardieri, E. Grossi

CER11473
2018,36,3,Suppl.112
Pg. 0145-0149

Free to view

A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sjögren’s syndrome
C. Notarstefano, C. Croia, E. Pontarini, D. Lucchesi, N. Sutcliffe, A. Tappuni, V. Donati, C. Pitzalis, C. Baldini, M. Bombardieri

CER11528
2018,36,3,Suppl.112
Pg. 0150-0156

Free to view

The evaluation of disease activity in Sjögren’s syndrome based on the degree of MALT involvement: glandular swelling and cryoglobulinaemia compared to ESSDAI in a cohort study
S. De Vita, S. Gandolfo, S. Zandonella Callegher, A. Zabotti, L. Quartuccio

Diagnosis

CER10753
2018,36,3,Suppl.112
Pg. 0157-0164

Free to view

Serum soluble interleukin-2 receptor is a useful biomarker for disease activity but not for differential diagnosis in IgG4-related disease and primary Sjögren’s syndrome adults from a defined population
M. Akiyama, T. Sasaki, Y. Kaneko, H. Yasuoka, K. Suzuki, K. Yamaoka, T. Takeuchi

CER11020
2018,36,3,Suppl.112
Pg. 0165-0172

Free to view

Diagnostic and predictive evaluation using salivary gland ultrasonography in primary Sjögren’s syndrome
K.-A. Lee, S.-H. Lee, H.-R. Kim

CER11358
2018,36,3,Suppl.112
Pg. 0173-0176

Free to view

Patient-reported change of sensibility and pain after parotid and labial gland biopsy applied for primary Sjögren’s syndrome diagnostics: one-year follow-up study
K. Delli, E.F. Dagal, H. Bootsma, A. Vissink, F.K. Spijkervet

Treatment

CER10180
2018,36,3,Suppl.112
Pg. 0177-0181

Free to view

Use and withdrawal of immunosuppressors in primary Sjögren’s syndrome
J. Torres-Ruiz, D. Faz-Muñoz, N. Hernández-Díaz, G. Hernandez-Molina

CER10968
2018,36,3,Suppl.112
Pg. 0182-0185

Free to view

Do antimalarials protect against damage accrual in primary Sjögren’s syndrome? Results from a Latin-American retrospective cohort
G. Hernández-Molina, V. Valim, A. Secco, Y. Atisha-Fregoso, E. Guerra, M. Adrover, A.J. Lage Santos, A. Catalán-Pellet

CER10929
2018,36,3,Suppl.112
Pg. 0186-0189

Free to view

Risk factors of relapse following glucocorticoid tapering in IgG4-related disease
T. Sasaki, M. Akiyama, Y. Kaneko, H. Yasuoka, K. Suzuki, K. Yamaoka, T. Takeuchi

Reviews

CER10784
2018,36,3,Suppl.112
Pg. 0190-0197

Free to view

Association between primary Sjögren’s syndrome, cardiovascular and cerebrovascular disease: a systematic review and meta-analysis
W.C. Yong, A. Sanguankeo, S. Upala

CER11368
2018,36,3,Suppl.112
Pg. 0198-0209

Free to view

Phenotyping Sjögren's syndrome: towards a personalised management of the disease
P. Brito-Zerón, S. Retamozo, M. Ramos-Casals

CER11373
2018,36,3,Suppl.112
Pg. 0210-0214

Free to view

Discrepancy between subjective symptoms, objective measures and disease activity indexes: the lesson of primary Sjögren’s syndrome
A. Alunno, E. Bartoloni, V. Valentini, G.M.C. La Paglia, E. Valentini, M.C. Leone, E. Marcucci, G. Cafaro, A.F. Bonifacio, F. Luccioli, R. Gerli

CER11475
2018,36,3,Suppl.112
Pg. 0215-0221

Free to view

Imaging in primary Sjögren’s syndrome: the 'obsolete and the new'
C. Baldini, A. Zabotti, N. Filipovic, A. Vukicevic, N. Luciano, F. Ferro, M. Lorenzon, S. De Vita

CER11503
2018,36,3,Suppl.112
Pg. 0222-0233

Free to view

The role of salivary gland histopathology in primary Sjögren’s syndrome: promises and pitfalls
F.G. Kroese, E.A. Haacke, M. Bombardieri

Case Report

CER11040
2018,36,3,Suppl.112
Pg. 0234-0236

Free to view

Primary myelofibrosis but not autoimmune myelofibrosis accompanied by Sjögren's syndrome and primary biliary cirrhosis in a patient with trisomy 8 mosaic: a case report and literature review
C. Lu, X. Wu, H. Wen, H. Gao, C. Wang, B. Yang, Z. Liang, C. Gao, X. Li

Letters to the Editor

CER10963
2018,36,3,Suppl.112
Pg. 0237-0238

Free to view

Superior oblique myositis causing acquired Brown’s syndrome as the first manifestation of primary Sjögren's syndrome
J.-S. Moon, S.Y. Shin

CER11383
2018,36,3,Suppl.112
Pg. 0239-0240

Free to view

Decrease in the ratio of polyreactive IgG titers with IgG concentration is associated with long-term complications of primary Sjögren's syndrome
O.D. Argyropoulou, S. Gunti, E.K. Kapsogeorgou, A.L. Notkins, A.G. Tzioufas

Meeting Abstracts

CER11665
2018,36,3,Suppl.112
Pg. 0241

Free to view

14th International Symposium on Sjögren’s Syndrome
A.N. Baer, E.K. Akpek, I. Alevizos
18-21 April 2018, Washington, DC, USA

CER11696
2018,36,3,Suppl.112
Pg. 0242-0255

Free to view

Oral presentations
No Author

CER11666
2018,36,3,Suppl.112
Pg. 0256-0332

Free to view

Poster presentations
No Author

CER11667
2018,36,3,Suppl.112
Pg. 0333-0338

Free to view

Author Index
No Author